Ikonisys strengthens its financial structure thanks to a capital increase

On November 19, 2024, Ikonisys SA announced that it had completed a capital increase of €200,000 through a private placement. This move is part of an ongoing effort to strengthen the financial strength of the company, which specializes in early cancer detection. The funds raised will contribute to financing working capital.

This transaction has been approved by the Board of Directors and the new shares will be issued on November 19, 2024. The issue price represents a slight discount compared to the closing price on November 18. The company thus estimates that it will be able to cover its financing needs for more than 12 months.

For a shareholder initially holding 1% of the capital, the stake drops slightly to 0.99% after the issue of the new shares. The distribution of capital shows minimal change, with an increase in the share of the float.